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ABSTRACT
Short cervical length (SCL) should be defined as a cervical length (CL) less than 25 mm between 18 and 22 weeks of gesta-
tion. This definition of SCL is fully applicable for singleton pregnancies, but is not entirely correct for twin pregnancies. Thus 
far, there are no explicit guidelines on the treatment of twin pregnancy with a SCL.
The use of progesterone in the treatment of SCL, and preterm birth (PTB) prophylaxis, is one of the interventions recom-
mended by the Polish Ministry of Health for cervical shortening in singleton pregnancies. In twin pregnancies, attention 
should be paid to the potential benefits of using vaginal progesterone in the reduction of neonatal mortality as well as 
lowering the incidence of neonatal complications; specifically in a group of patients with twin pregnancies and CL less 
than 25 mm or below the 10th percentile for the gestational age, measured between 18 and 22 weeks of gestation.
It remains difficult to ascertain the benefits of using pessaries in the prevention of PTB in twin pregnancies. The usage of 
pessaries appears to be beneficial only in selected subpopulations of patients with asymptomatic CLs less than 25 mm or 
10th percentile for gestational age.
The use of cervical cerclage in PTB prevention in twin pregnancies is limited to cases where the external cervical dilation 
is > 1 cm and < 4 cm between 16 and 24 weeks of gestation. 
Considering the necessity for screening for asymptomatic shortening of the cervix in twin pregnancies, establishing 
a standard practice in the case of positive screening results is seemingly crucial.
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INTRODUCTION
Cervical incompetence (CI) is defined as a painless dila-
tion and shortening of the cervix in the absence of vaginal 
bleeding, uterine contraction and the preterm rupture of 
membranes, ending with either miscarriage or childbirth 
during the second trimester of pregnancy [1]. CI is part of 
a broader concept of a short cervix. Short cervical length 
(SCL) should be defined as a CL less than 25 mm between 
18 and 22 weeks of gestation. This definition of SCL is fully 
applicable for singleton pregnancies and is used in the 
treatment recommendations, but does not entirely apply 
towards twin pregnancies. A number of authors and medical 
associations suggest to define the short cervix as a cervical 
length below the 10th percentile for a given gestational 
age. In the pathogenesis of the short cervix, both congenital 
factors (e.g. anatomical anomalies) and acquired factors may 
play an important role, including: cervical surgery, cervical 
trauma and systemic diseases associated with collagen and 
elastin disorders, as well as excessive mechanical pressure 
exerted on the cervix [2, 3].
Cervical length evolves during pregnancy and dimi-
nishes with the duration of pregnancy. The dynamics and 
degree of these changes depend on the number of fetu-
ses [4]. In cases involving multiple pregnancies, it is difficult 
to clearly define the boundaries between the pathological 
shortening of the cervix due to its dysfunction and the 
natural processes that occur during pregnancy which are 
exacerbated by the presence of more than one fetus.
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So far, there are no explicit guidelines on the treatment 
of twin pregnancy with excessive cervical shortening. Cur-
rent recommendations for short cervix established for sin-
gleton pregnancies cannot be fully utilised in patients with 
twin pregnancy, presumably due to different mechanisms 
that lead to cervical shortening. Delineating the treatment 
protocol in twin pregnancies is essential in order to reduce 
the preterm birth (PTB) rate, as there are efficient methods 
for early detection of short cervix.
DIAGNOSIS OF SHORT CERVIX  
IN TWIN PREGNANCY
According to the standards of perinatal care, constituted 
by the Polish Ministry of Health, patients with twin pregnancy 
should have a transvaginal ultrasound examination with a ce-
rvical length (CL) measurement performed between 18 and 
22 weeks of gestation. If the CL is less than 25 mm in a given 
period, the patient should be classified as having an increased 
risk of PTB [5]. Apart from the obligations to conduct scre-
enings for asymptomatic cervical shortening for the general 
population, the current guidelines outlined by the Ministry of 
Health clearly solely define the possible treatment strategies 
in singleton pregnancies, without taking into account twin 
pregnancies that carry an increased risk of PTB [5].
The benefit of screening for the asymptomatic shorte-
ning of the cervix in twin pregnancy has been repeatedly 
confirmed in available literature [6–8]. In 1996, Goldenberg 
et al. showed that a CL less than 25 mm at 24 weeks of 
gestation is associated with an increased risk of PTB before 
37 weeks of gestation [OR 6.9; 95% CI 2.0–24.2)] [9]. In the 
meta-analysis by Conde-Agudelo, Romero et al. [10], the 
results of 21 studies on cervical length measurements in 
twin pregnancy were evaluated. It has been shown that 
a CL less than 20 mm between 20 and 24 weeks gestation 
increases the risk of PTB before 32 weeks of gestation from 
6.8% to 42.4%, and the risk of PTB before 34 weeks of ge-
station from 15.3% to 61.9%, respectively. Moreover, a CL 
less than 25 mm appeared to increase the risk of PTB before 
28 weeks of gestation from 3.5% to 25.8% and from 41.2% 
to 75.5% before 37 weeks of gestation [10].
Recent studies indicate that serial cervical length measu-
rements in twin pregnancies may provide a better tool for 
screening for cervical shortening. The study by Melamed et 
al. [11], published in the American Journal of Obstetrics and 
Gynecology in 2016, indicates the benefits of serial cervical 
length measurements using transvaginal ultrasound in pa-
tients with high risk for PTB before 32 weeks of gestation. 
In this study, a total of 441 patients with twin pregnancies 
underwent serial measurements of cervical length between 
18 and 21 + 6 (period 1), 22 and 24 + 6 (period 2), 25 and 
27 + 6 (period 3) and 28 and 32 and 32 (Period 4) weeks 
of gestation. Both values — absolute cervical length and 
the degree (in percentages) of cervical shortening — were 
compared during respective periods. There was a statisti-
cally significant association between cervical length be-
low the 10th percentile in each of the 4 periods and an in-
creased risk of PTB before 32 weeks of gestation [period 
1 — RR = 7.2 (3.1–16.5), period 2 — RR = 15.3 (6.4–36.7), 
period 3 — RR = 10.3 (4.4–24.3), period 4 — RR = 23.1 (8.3–
–64.1)]. Furthermore, the advantage of serial cervical length 
measurements was demonstrated. In relation to the single 
measurement in period 1, the serial cervical length measu-
rements in all 4 periods were associated with an increased 
detection rate of PTB prior to 32 weeks of gestation (69% 
vs. 28% for single measurement, p < 0.001), increased po-
sitive predictive value (14.54 vs. 5.21) and decreased nega-
tive predictive value (0.32 vs. 0.76). The results of the study 
imply the practicality of defining the short cervix as shorter 
than 10th percentile for a given gestational age and the 
clinical relevance of serial cervical length measurements in 
the prevention of preterm labour. 
Funneling of the internal cervical os could also be used 
as an additional tool in the prediction of PTB in twin pre-
gnancies. A paper by Vayssière et al. [12] assesses the accu-
racy of cervical length and funneling of the internal os in the 
prediction of PTB in twin pregnancies. The results for internal 
os funneling showed that the sensitivity of funneling measu-
red at 22 weeks of gestation in prediction of PTB < 32 and 
35 weeks of gestation were 54% and 33%; and their specifici-
ty was 89% and 91%, respectively. For PTB < 32 and 35 weeks 
of gestation, the sensitivity of CL ≤ 30 mm measured at 
22 weeks of gestation was 46% and 27%, respectively; the 
specificity was 89% and 90%, respectively. Funneling me-
asurements at 27 weeks of gestation exhibited sensitivity 
values of 86% and 54% and specificity values of 78% and 
82% in predicting PTB at < 32 and 35 week of gestation. 
For PTB < 32 and 35 weeks of gestation, the sensitivity of 
cervical length ≤ 25 mm measured at 27 week of gestation 
was correspondingly 100% and 54%, and the specificity was 
84% and 87%, respectively [12]. 
Another possible tool for predicting PTB is the detection 
of the cervical gland area. A paper by Yoshimatsu et al. [13] 
showed that in the normal pregnancy group (260 single-
ton pregnancies), the detection rate of the cervical gland 
area remained practically constant until the 31st week of 
pregnancy (97%), but substantially decreased thereafter 
(70.2% in gestational weeks 32–35). In the threatened PTB 
group (101 singleton pregnancies), the detection rate of 
the cervical gland area was consistently lower (44.5%) [13]. 
Unfortunately, the current research on the usefulness of 
cervical gland detection in predicting PTB in twin pregnan-
cies is lacking.
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PHARMACOLOGICAL METHODS  
— ROLE OF THE PROGESTERONE  
IN THE PROPHYLAXIS OF SHORT CERVIX
The use of progesterone in the treatment of SCL and 
PTB prophylaxis is one of the interventions recommended 
by the Polish Ministry of Health for cervical shortening in 
singleton pregnancies [5]. This procedure is proven effica-
cious and has been repeatedly verified in clinical trials. In 
2012, Romero, Nicolaides et al. [14] published a meta-ana-
lysis of randomized clinical trials on vaginal progesterone in 
pregnant women with asymptomatic shortening of cervix 
in the second trimester of pregnancy. The decrease was 
noted in PTB before 28 weeks of gestation (RR 0.51; 95% CI 
0.31–0.85), before 33 weeks of gestation (RR 0.56, 95% CI 
0.40–0.80) and before 35 weeks of gestation (RR 0.67; 95% 
CI 0.51–0.87). In addition, the use of vaginal progesterone 
was associated with a reduction in neonatal mortality and 
neonatal morbidity (RR 0.59; 95% CI 0.38–0.91). However, for 
twin pregnancies with asymptomatic cervical shortening, 
with a CL less than 25 mm in the second trimester, a stati-
stically insignificant trend toward a reduction in the preva-
lence of PTB before 33 weeks was demonstrated; moreover, 
vaginal progesterone was shown to be associated with 
a 48% reduction in neonatal mortality and the incidence 
of neonatal complications (RR 0.52; 95% CI 0.29–0.93) [14]. 
These observations were confirmed by Schuit et al. in a me-
ta-analysis of vaginal progesterone, in patients with twin 
pregnancies, in order to reduce the incidence of neonatal 
complications [15]. It has been shown that the routine use 
of vaginal progesterone in all twin pregnancies does not 
reduce neonatal mortality or neonatal morbidity (RR 0.97; 
95% CI 0.77–1.2). Nonetheless, in a selected subgroup of 
patients with CL less than 25 mm before 24 weeks of gesta-
tion, vaginal progesterone significantly reduced neonatal 
mortality and the incidence of neonatal complications (RR 
0.56; 95% CI 0.42–0.75) [15].
The daily recommended dose of progesterone is 
90 mg in gel and 200 mg in vaginal tablets (100 mg twice 
a day)  [14]. The efficacy of higher doses of progesterone 
(400 mg) in the reduction of PTB, neonatal mortality and 
morbidity was not demonstrated. Furthermore, a statistically 
insignificant trend toward a higher incidence of pregnancy 
cholestasis was shown in a subgroup of patients receiving 
higher doses of progesterone [16].
In conclusion, attention should be paid to the potential 
benefits of using vaginal progesterone in the reduction of 
neonatal mortality and the incidence of neonatal complica-
tions in the group of patients with twin pregnancies — a CL 
of less than 25 mm or below the 10th percentile for the 
gestational age — measured between 18 and 22 weeks 
of gestation.
MECHANICAL METHODS  
— USE OF PESSARIES AND CERVICAL 
CERCLAGE FOR THE TREATMENT OF SHORT 
CERVIX IN TWIN PREGNANCIES
The unequivocal benefits of using pessaries in the pre-
vention of SCL in twin pregnancies have not been establi-
shed, as the results of clinical trials are contradictory. In 2013, 
the results of the ProTWIN study published in the Lancet, 
evaluated the efficacy of pessaries in PTB prophylaxis in 
twin pregnancies [17]. There were no statistically significant 
differences in the obstetric or neonatal outcomes in the 
group of patients with pessaries administered between 
16 and 20 weeks of gestation. The use of pessaries did not 
reduce PTB in < 28, < 32 and < 37 weeks of gestation (RR 
0.79, 95% CI 0.50–1.27; RR 0.86, 95% CI 0.65–1.15; RR 0.94, 
95% CI 0.87–1.07, respectively). There were no differences 
in the incidence of neonatal complications (RR 0.98; 95% 
CI 0.69–1.39). However, it is worth to note that in the ana-
lysis of the subgroup of patients whose cervical length, 
between 16 and 20 weeks, was less than the 25th percentile 
(corresponding to 38 mm in the study population), pessary 
administration resulted in statistically significant prolonga-
tion of pregnancy (p = 0.0106, RR 0.49; 95% CI 0.32–0.77). 
In addition, the incidence of neonatal complications was 
statistically significantly lower (p = 0.0106, RR 0.4, 95% CI 
0.19–0.83), as well as the risk of PTB before 28 weeks of ge-
station (p = 0.0158, RR 0.23, 95% CI < 0.06–0.87) and before 
32 weeks of gestation (p = 0.0476, RR 0.49; 95% CI 0.24–0.97). 
This study shows that in twin pregnancies the norms for CL, 
in comparison to the norms of CL for singleton pregnancies, 
are different. As such, the treatment should be initiated in 
twin pregnancies even if the results are within the norms 
for CL in the singleton pregnancies.
In 2016, the results of two randomised clinical trials were 
published almost simultaneously in the American Journal 
of Obstetrics and Gynecology. The initial publication in Ja-
nuary, by Goya et al. [18], evaluated the efficacy of pessaries 
administered between 20 and 24 weeks of gestation in the 
prevention of PTB among twin pregnancies. There were no 
statistically significant differences in the incidence of PTB 
before 34 weeks of gestation (RR 1.054, 95% CI 0.787–1.413) 
as well as neonatal mortality (RR 0.908, 95% CI 0.553–1.491), 
neonatal complications (RR 1.094; 95% CI 0.851–1.407) and 
the incidence of neonatal intensive care procedures (RR 
1.040; 95% CI 0.871–1.242).
As evidenced in the ProTWIN study, there was a post-
-hoc analysis of the subgroup of patients with a CL less 
than 25mm between 20 and 24 weeks of gestation, but there 
were no statistically significant differences in incidence of 
PTB before 34 weeks of gestation as well as no reduction in 
neonatal complications. 
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Previously discussed conflicting results are partially clari-
fied in the PECEP-Twins study published in February 2016 in 
the American Journal of Obstetrics and Gynaecology. The 
study evaluates the use of pessaries in PTB prevention in 
twin pregnancies with an asymptomatic short cervix [19]. 
Patients with a cervical length less than 25mm between 
18 and 22 weeks of gestation were included in the study. The 
use of pessaries significantly reduced the incidence of PTB 
before 34 weeks of gestation (RR 0.41; 95% CI 0.22–0.76). In 
addition, the use of pessaries was associated with a statisti-
cally significantly lower risk of birth weight less than 2500 g 
(RR 0.72; 95% CI 0.54–0.97). However, these changes did 
not affect the incidence of neonatal complications (RR 0.64; 
95% CI 0.27–1.50). Moreover, the incidence of side effects 
resulting from pessary usage was assessed in the study. 
However, despite a significant increase in rate of excessive 
vaginal discharge (100% in the study group vs. 53% in the 
control group), this did not result in the increased number 
of bacteriologically positive vaginal swabs and the necessity 
for antibiotic therapy.
Taking into consideration the results of the mentioned 
studies, it is still difficult to clearly identify the benefits of 
using pessaries in the prevention of PTB in twin pregnan-
cies. The usage of pessaries appears to be beneficial only 
in selected subpopulations of patients presenting with 
an asymptomatic CL less than 25 mm or 10th percentile 
for gestational age.
The benefits of cervical cerclage in the prevention of 
PTB in twin pregnancies have not been unequivocally iden-
tified and, in addition, this procedure is controversial. The 
guidelines issued by the American College of Obstetricians 
and Gynaecologists (ACOG), the Society of Obstetricians 
and Gynaecologists of Canada (SOGC), and the Royal Col-
lege of Obstetricians and Gynaecologists (RCOG) do not 
recommend the use of cervical cerclage in the prevention 
of PTB in twin pregnancies, as there are reports that such 
intervention may increase the risk of preterm delivery in 
this group of patients [20–22]. In 2005, Berghella et al. [23] 
published a meta-analysis of 4 randomized clinical trials 
that assessed the efficacy of cervical cerclage in both single 
and multiple pregnancies. Additionally, a subgroup of twin 
pregnancies with a CL less than 25 mm, confirmed via ultra-
sound, was selected. The research showed that in this group, 
the increased risk of PTB before 35 weeks of gestation was 
statistically significant (RR 2.15, 95% CI 1.15–4.01), and there 
was a statistically insignificant increased risk of neonatal 
death [RR 2.66; 95% CI 0.83–8.54). However, a retrospective 
cohort study by Roman et al. [24], published in 2016 in the 
American Journal of Obstetrics and Gynaecology, indica-
tes that the use of cervical cerclage can be beneficial in 
a selected group of women with twin pregnancies. The 
analysis included perinatal and neonatal outcomes in twin 
pregnancies, with cervical dilation ranging from 1 to 4 cm, 
that underwent cervical cerclage between 16 and 24 we-
eks of gestation. A statistically significant reduction of PTB 
at < 34, < 32, < 28 and < 24 weeks of gestation was observed 
in this group of patients (p < 0.05), 95% CI 0.03–0.34, aOR 
0.08, 95% CI 0.03–0.34 AOR 0.05; 95% CI 0.01–0.2; aOR 0.17; 
95% CI 0.05–0.54, respectively). In addition, there was a re-
duction in neonatal mortality (aOR 0.24, 95% CI 0.11–0.5) as 
well as neonatal complications (aOR 0.05; 95% CI 0.01–0.21).
Based on the results of the aforementioned research, it 
appears that the use of cervical cerclage for PTB prevention 
in twin pregnancies is limited to cases where the external 
cervical dilation is > 1 cm and < 4 cm, between 16 and 24 we-
eks of gestation. The current data pertaining to the efficacy 
of cervical cerclage — in the group of patients exhibiting 
a shortened cervix without dilation — are conflicting and 
prove difficult in providing a definitive conclusion.
SUMMARY
Considering the necessity of screening patients with twin 
pregnancies for asymptomatic shortening of the cervix, esta-
blishing a standard practice in the case of a positive screening 
result is crucial. Based on the aforementioned data derived 
from the previously discussed medical literature, summari-
sed in Table 1, the proposed algorithm is presented in Figu-
re 1. All women with twin pregnancies should be included 
in the screening that is carried out between 18 and 22 week 
of gestation. In the case of a negative screening result, CL 
measurements should be serially repeated with the aid of 
a transvaginal ultrasound. The effectiveness of routinely ad-
ministrated vaginal progesterone, in patients with a normal 
CL in their current pregnancy with a previous history of PTB, 
should be evaluated. In the case of a positive screening result, 
the patient should be advised to start vaginal progesterone 
supplementation at a dose of 200 mg daily (100 mg twice 
a day) or at a dose of 90 mg in gel until delivery, in an effort 
to reduce both neonatal mortality and the incidence of neo-
natal complications. In the case of continued shortening of 
the cervix without dilation, it appears reasonable to insert 
a pessary until the 26th week of gestation. Alternatively, in 
situations were the shortening of the cervix proceeds with 
dilation of the cervix, despite the use of vaginal progesterone, 
the use of cervical cerclage should be considered beneficial 
up to the 24th week of gestation. It is important to note that 
both the pessary and cervical cerclage should be removed 
before the onset of uterine contraction. 
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Table 1. Summary of the discussed studies that are included in the algorithm






et al. (1996) [9] PCS
To determine the association 
between the presence  
a short cervix and the risk  
of spontaneous preterm birth  
of twins
147 patients
CL < 25 mm at 24 weeks of gestation is associated with 




Romero et al. 
(2010) [10]
SRM
To assess the accuracy  
of transvaginal sonographic 
cervical length (CL) in predicting 
spontaneous preterm birth in 
women with twin pregnancies
21 trials
CL < 20 mm between 20 and 24 weeks gestation increases 
the risk of PTB < 32 weeks of gestation from 6.8% to 42.4%, 
and the risk of PTB < 34 weeks of gestation from 15.3% to 
61.9%
CL < 25 mm appeared to increase the risk of PTB < 28 weeks 
of gestation from 3.5% to 25.8% and from 41.2% to 
75.5% < 37 weeks of gestation
Melamed et al. 
(2016) [11] RCS
To determine whether 
serial measurements of CL 
can improve prediction of PTB  
in asymptomatic women  
with twin pregnancy
441 patients
In relation to the single measurement, the serial CL 
measurements were associated with an increased detection 
rate of PTB < 32 weeks of gestation (69% vs. 28% for single 
measurement, p < 0.001), increased positive predictive 
value (14.54 vs. 5.21) and decreased negative predictive 
value (0.32 vs. 0.76)
Romero, 
Nicolaides  




To determine whether the 
use of vaginal progesterone 
in asymptomatic women with 
a sonographic CL ≤ 25 mm in the 
midtrimester reduces the risk 
of PTB and improves neonatal 
morbidity and mortality
5 trials
For twin pregnancies with asymptomatic CL < 25 mm 
in the second trimester, a statistically insignificant trend 
toward a reduction in the prevalence of PBR < 33 weeks 
was demonstrated. Vaginal progesterone was shown to be 
associated with a 48% reduction in neonatal mortality and 
the incidence of neonatal complications (RR 0.52; 95% CI 
0.29–0.93)
Figure 1. Proposed algorithm for the management of twin pregnancies complicated by asymptomatic shortening of the cervix
CL > 25 mm or > 10th percentile
CL < 25 mm or < 10th percentile
No dilatation
CL < 10th percentile
Dilation 1–4 cm
Serial TV-USG in 22–24, 25–27,
28–32 weeks of gestation
Progesterone vaginally 
2 × 100 mg tablets  or 90 mg gel
Removal and delivery:
32 weeks of gestation 1D 1D
36 weeks of gestation 1D 2D
37–38 weeks of gestation 2D 2D
Further shortening of the cervix
TV-USG between 18
and 22 weeks of gestation
Cervical cerclage
until 24th week of gestation 
Pessary
until 26th week of gestation
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Table 1. Summary of the discussed studies that are included in the algorithm (cont.)









To assess the effectiveness  
of progesterone treatments 
in the prevention of neonatal 
morbidity or PTB in twin 
pregnancies
13 trials
In a selected subgroup of patients with CL less than 25 mm 
before 24 weeks of gestation, vaginal progesterone 
significantly reduced neonatal mortality and the incidence 
of neonatal complications (RR 0.56; 95% CI 0.42–0.75)
Liem et al. 
(2013) [17] RCT
To assess whether a cervical 
pessary could effectively prevent 
poor perinatal outcomes
808 patients
In the subgroup of patients whose CLs were between 
16 and 20 weeks was < 25 percentile (in the study 
population corresponds to 38 mm), pessary administration 
resulted in the statistically significant prolongation of 
pregnancy (p = 0.0106, RR 0.49; 95% CI 0.32–0.77).  
In addition, the incidence of neonatal complications was 
statistically significantly lower (p = 0.0106, RR 0.4, 95% CI 
0.19–0.83), as well as the risk of PTB < 28 weeks of gestation 
(p = 0.0158, RR 0.23, 95% CI < 0.06–0.87) and < 32 weeks  
of gestation (p = 0.0476, RR 0.49; 95% CI 0.24–0.97)
Nicolaides  
et al. (2016) 
[18]
RCT
To evaluate the efficacy of 
pessaries administered between 
20 and 24 weeks of gestation for 
prevention of PTB among twin 
pregnancies 
1180 patients
There were no statistically significant differences in the 
incidence of PTB < 34 weeks of gestation (RR 1.054, 95% CI 
0.787–1.413) as well as neonatal mortality (RR 0.908, 95% CI 
0.553–1.491), neonatal complications (RR 1.094; 95% CI 
0.851–1.407) and the incidence of neonatal intensive care 
procedures (RR 1.040; 95% CI 0.871–1.242)
Goya et al. 
(2016) [19] RCT
The study evaluates the use 
of pessaries in PTB prevention 
in twin pregnancies with 
asymptomatic short cervix 
2287 patients
The use of pessaries significantly reduced the incidence 
of PTB before 34 weeks of gestation (RR 0.41; 95% CI 
0.22–0.76). In addition, the use of pessaries was associated 
with a statistically significantly lower risk of birth weight 
less than 2500 g (RR 0.72; 95% CI 0.54–0.97). However, 
these changes did not affect the incidence of neonatal 
complications (RR 0.64; 95% CI 0.27–1.50)




To assess the efficacy of cervical 
cerclage in both single and 
multiple pregnancy
4 trials
In a subgroup of twin pregnancies with CL < 25 mm the risk 
of PTB < 35 weeks of gestation was statistically significantly 
increased (RR 2.15, 95% CI 1.15–4.01), and there was 
a statistically insignificant increased risk of neonatal death 
[RR 2.66; 95% CI 0.83–8.54)
Roman et al. 
(2016) [24] RCS
To compare the perinatal 
outcomes of twin pregnancies 
with a dilated cervix in women 
who underwent either cerclage 
or expectant management.
8 trials
In twin pregnancies with cervical dilation ranging from 1 to 
4 cm, that underwent cervical cerclage between 16 and 
24 weeks of gestation, there were statistically significant 
reductions of PTB < 34, < 32, < 28 and < 24 weeks of 
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PCS — prospective cohort study; SRM — systematic review and meta-analysis; RCS — retrospective cohort study; RCT — randomised controlled trials; CL — cervical 
length; PTB — preterm birth
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